Mobilizing Recovery Resources to Improve HIV Care for People Using Methamphetamine
Official title: Mobilizing Recovery Capital to Improve Outcomes for People living with HIV and Methamphetamine Use Disorder
Funded at Emory University · NIH-11409122 · Data updated 2026-11-12
A patient-friendly project to help people living with HIV who use methamphetamine strengthen personal and community supports to stay engaged in care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | August 15, 2026 |
| Project end | May 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $210,750 |
| NIH project number | 1R34DA066379-01 |
| Project ID | NIH-11409122 on NIH RePORTER |
Who could benefit from this research
✓Could help
People living with HIV who use methamphetamine and their loved ones who are willing to participate in recovery-support activities.
✕Less likely to help
Not all individuals may benefit if they are not connected to care or willing to participate in community-based activities.
What this research studies
This project, based at Emory University, develops a new program called UPLIFT to tap into recovery assets across individuals, families, and communities. It will start with conversations and photovoice interviews to understand what helps people recover and stay connected to HIV care. Then a community-designed plan will be created to use these strengths to improve treatment engagement and support for loved ones. The team will pilot the program with people living with HIV who use methamphetamine and refine it based on participant feedback.
Why it matters
Potential benefit: If successful, the intervention could improve HIV care engagement and support recovery for people who use methamphetamine.
How similar studies have gone: This approach builds on recovery capital concepts that have shown promise but is a new, multi-level community-engaged intervention.
Where this research is happening
-
Emory University
Atlanta, United States Active
Researchers
- Principal investigator: Hussen, Sophia a. — Emory University
- Study coordinator: Hussen, Sophia a.
Related research
Other NIH-funded projects on the same topics.
-
Calming cue-triggered cravings in methamphetamine use
Seeing if teaching people with methamphetamine use disorder a thinking-based skill (cognitive reappraisal) can reduce brain and craving reactions to drug cues.
-
Psilocybin for treatment of methamphetamine use disorder
A study is testing whether psilocybin can help people with methamphetamine use disorder feel better and stay abstinent, starting with a small, carefully monitored group.
-
Reducing Methamphetamine Use to Improve Health and Well-Being
A clinical trial tests whether giving incentives to people with methamphetamine use disorder helps them use less meth and improves heart, immune, sleep, and psychosocial health.
-
Psilocybin-assisted therapy for methamphetamine use disorder in people with HIV
A small, carefully controlled study will test whether psilocybin, given with support, can help people living with HIV who have moderate-to-severe methamphetamine use disorder.
-
Tirzepatide for Methamphetamine Use Disorder in adults with diabetes
A study will test whether an approved diabetes drug, tirzepatide, helps adults with methamphetamine use disorder who have diabetes.
-
Parkin helps brain energy stay steady in meth use disorder
Aims to see if boosting a brain protective protein called parkin can reduce cravings and risky behavior in people (via a rat model and related studies) who struggle with methamphetamine use disorder.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.